NLM Digital Collections

Search

Start Over Subjects Medicare Part D ✖Remove constraint Subjects: Medicare Part D

1. Part D plans generally include drugs commonly used by dual eligibles: 2018

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Drug Utilization
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Medicare Part D
Insurance Benefits
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
United States.

2. Opioid use in Medicare Part D remains concerning

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Analgesics, Opioid -- economics
Fentanyl -- adverse effects
Prescription Drug Diversion
Humans
United States
United States. Department of Health and Human Services.

4. The Medi-Cal prescription drug benefit: an overview

Publication:
Oakland, Calif. : California HealthCare Foundation, [2009]
Subject(s):
Health Expenditures -- trends
Insurance Benefits
Insurance, Pharmaceutical Services
Medicaid
Prescription Drugs -- economics
Adult
Aged
Child
Cost Control
Cost Sharing
Disabled Persons
Drug Costs
Drug Utilization Review
Drugs, Generic
Fee-for-Service Plans
Forecasting
Managed Care Programs
Medicare Part D
Middle Aged
Humans
California

6. Medicare Advantage 2017 spotlight: enrollment market update

Author(s):
Jacobson, Gretchen, author
Damico, Anthony, author
Neuman, Tricia, author
Gold, Marsha, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, June 2017
Subject(s):
Medicare Part C -- statistics & numerical data
Medicare Part C -- trends
Cost Sharing
Forecasting
Health Maintenance Organizations
Medicare Part D
Quality of Health Care
State Government
Humans
United States

7. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

12. Electronic prescribing of controlled substances among office-based physicians: 2017

Author(s):
Parasrampuria, Sonal, author
Blanco, Martin, author
Barker, Wesley, author
Publication:
Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, September 2019
Subject(s):
Controlled Substances
Electronic Prescribing -- statistics & numerical data
Practice Patterns, Physicians' -- statistics & numerical data
Prescription Drug Diversion -- prevention & control
Electronic Health Records
Medicare Part D
United States
United States. Department of Health and Human Services.

14. Concerns about opioid use in Medicare Part D in the Appalachian region

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Drug Utilization -- statistics & numerical data
Inappropriate Prescribing -- statistics & numerical data
Prescription Drug Diversion -- statistics & numerical data
Prescription Drug Monitoring Programs
Humans
Appalachian Region
United States

15. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

16. Some Medicare Part D beneficiaries face avoidable extra steps that can delay or prevent access to prescribed drugs

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019
Subject(s):
Health Services Accessibility
Insurance Coverage
Medicare Part D
Prescription Drugs
Formularies as Topic
Insurance Coverage -- statistics & numerical data
Humans
United States